FDA to consider annual or biannual partnership meetings with industry, consumers.
This article was originally published in The Tan Sheet
Executive Summary
FDA WILL CONSIDER REGULAR PARTNERSHIP MEETINGS WITH INDUSTRY, CONSUMERS as a result of concerns raised by representatives of the pharmaceutical industry, academia, consumer groups and state and federal regulators at the agency's "grassroots regulatory partnership meetings" held in five regional locations across the country during the last week of April. Improved and consistent agency communication was a common theme of the half-day public sessions.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning